IFP Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$159K Sell
482
-182
-27% -$61.9K ﹤0.01% 1523
2025
Q4
$264K Buy
664
+173
+35% +$76.6K 0.01% 1228
2025
Q3
$224K Buy
491
+291
+146% +$118K 0.01% 1226
2025
Q2
$81.5K Sell
200
-32
-14% -$8.86K ﹤0.01% 1764
2025
Q1
$62.6K Sell
232
-9
-4% -$2.31K ﹤0.01% 1781
2024
Q4
$56.7K Buy
241
+47
+24% +$12.4K ﹤0.01% 1774
2024
Q3
$53.6K Buy
194
+145
+296% +$37.8K ﹤0.01% 1702
2024
Q2
$11.9K Sell
49
-421
-90% -$66.5K ﹤0.01% 2284
2024
Q1
$70.2K Buy
470
+14
+3% +$2.33K ﹤0.01% 1449
2023
Q4
$87.2K Buy
456
+2
+0.4% +$341 ﹤0.01% 1305
2023
Q3
$80.3K Buy
454
+1
+0.2% +$191 ﹤0.01% 1361
2023
Q2
$86K Sell
453
-3
-0.7% -$595 ﹤0.01% 1381
2023
Q1
$45.9K Sell
456
-203
-31% -$42.7K ﹤0.01% 1623
2022
Q4
$80K Sell
659
-224
-25% -$47.8K ﹤0.01% 1890
2022
Q3
$109K Buy
883
+143
+19% +$27.3K ﹤0.01% 1792
2022
Q2
$93K Hold
740
﹤0.01% 1726
2022
Q1
$93K Buy
740
+363
+96% +$55.3K ﹤0.01% 1726
2021
Q4
$73K Buy
377
+7
+2% +$1.3K ﹤0.01% 1399
2021
Q3
$77K Buy
370
+15
+4% +$2.81K ﹤0.01% 1402
2021
Q2
$60K Buy
355
+320
+914% +$46.9K ﹤0.01% 1446
2021
Q1
$5K Buy
35
+23
+192% +$3.46K ﹤0.01% 2391
2020
Q4
$1K Sell
12
-1
-8% -$134 ﹤0.01% 2721
2020
Q3
$1K Buy
13
+4
+44% +$568 ﹤0.01% 2592
2020
Q2
$1K Hold
9
﹤0.01% 2496
2020
Q1
$1K Hold
9
﹤0.01% 2478
2019
Q4
$1K Hold
9
﹤0.01% 2622
2019
Q3
$1K Buy
+9
New +$712 ﹤0.01% 2819
2019
Q1
Sell
-200
Closed -$14K 2378
2018
Q4
$14K Sell
200
-361
-64% -$27.8K ﹤0.01% 2320
2018
Q3
$49K Buy
561
+100
+22% +$10.1K ﹤0.01% 1905
2018
Q2
$45K Buy
+461
New +$45.7K ﹤0.01% 1976
2017
Q4
Sell
-107
Closed -$13K 3788
2017
Q3
$13K Buy
+107
New +$9.13K ﹤0.01% 2863
2016
Q3
Sell
-220
Closed -$12K 3885
2016
Q2
$12K Buy
+220
New +$13.9K ﹤0.01% 2644
2016
Q1
Sell
-278
Closed -$26K 2379
2015
Q4
$26K Buy
+278
New +$25.8K ﹤0.01% 2004

Other funds holding ALNY